Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 3 5Phase NA 3Phase 4 3Phase 1/2 1Phase 1 1

Status

Unknown 4Terminated 1

Sponsor Class

OTHER 5OTHER_GOV 1NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 4Lymphoid 1Gastrointestinal 1

Conditions

Multiple Myeloma 4Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Familial primary gastric lymphoma 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Clarithromycin × Clear all
NCT02516696 2023-06-05

BiRd vs Rd

Weill Medical College of Cornell University

Phase 3 Terminated
12 enrolled 19 charts
Plasma cell

Multiple Myeloma

NCT02575144 2022-02-01

GEM-CLARIDEX

PETHEMA Foundation

Phase 3 Unknown
286 enrolled
Plasma cell

Multiple Myeloma

NCT04287660 2021-10-25

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

The First Affiliated Hospital of Soochow University

Phase 3 Unknown
20 enrolled
Plasma cell

Multiple Myeloma

NCT02248428 2017-09-06

CTd

Jinling Hospital, China

Phase 3 Unknown
130 enrolled
Plasma cell

Multiple Myeloma

NCT00154440 2007-03-26

Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation

Technische Universität Dresden

Phase 3 Unknown
200 enrolled
GastrointestinalLymphoid

Familial primary gastric lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡